We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
ACCEPT Reject
Already have an account? Sign in.

 Remember Me | Forgot Your Password?
Home Manage Alerts Archive Archive About Us Register Now   Not a User? Join now

New Weight Control Drug Leaps First FDA Hurdle

July 21, 2009: 09:31 AM EST
A new diet pill that works by suppressing food cravings in the brain has cleared the first FDA approval hurdle by proving to be effective in a clinical trial involving nearly 3,000 people. The drug also needs to be proven safe to win full FDA clearance. Trial participants who took Contrave from Orexigen Therapeutics Inc. for a year lost an average of 17 pounds, eight times the loss experienced by those who took a placebo. While some experts said controlling cravings at the brain level is the wave of the future, others felt it is the wrong way to control weight.
LAUREN COX, "New Diet Drug Attacks Craving Center", ABC News Medical Unit, July 21, 2009, © ABC News Internet Ventures
Domains
DIET NEWS
Diet Insights
Weight Loss Programs
Other Diets
Diet Research & Advice
Market News
Geographies
Worldwide
North America
United States of America
Categories
Companies, Organizations
Consumers
Marketing & Advertising
Products & Brands
Research, Studies, Advice
Home | Privacy Policy | Terms and Conditions | Contact Us Copyright © 2000-2024 Business360 Inc. All Rights Reserved
Developed by Yuri Ingultsov Software Lab.